Pelvic Floor Disorders in Multiple Sclerosis Patients
Clinical and Neurophysiological Assessment of Pelvic Floor Dysfunction in Patients With Multiple Sclerosis
1 other identifier
observational
120
0 countries
N/A
Brief Summary
Primary objective
- Studying the effect of low frequency rTMS on bladder symptoms in patients with MS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2023
CompletedFirst Posted
Study publicly available on registry
June 25, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedJune 25, 2024
June 1, 2024
1 year
December 6, 2023
June 19, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical assessment of bowel, bladder, and sexual dysfunction in patients with MS though applying specific related scales
Clinical assessment of bowel, bladder, and sexual dysfunction in patients with MS though applying specific related scales
Baseline
Secondary Outcomes (1)
Motor evoked potential using TMS with parameters gained using single pulse paradigm
Baseline
Eligibility Criteria
Patient diagnosed with multiple sclerosis according to McDonald's criteria 2017 attending outpatient clinic, department of neurology and psychiatry, Assuit university hospital
You may qualify if:
- Adult patient with definite Multiple sclerosis 2-Age \> 18 years 3-both sexes 4-patient with complaint of any of pelvic floor dysfunction (bladder, sexual or bowel)
You may not qualify if:
- Patients with other systemic or neurological disorder affecting sphincter.
- Patients taking drugs affecting sphincter.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Belbasis L, Bellou V, Evangelou E, Tzoulaki I. Environmental factors and risk of multiple sclerosis: Findings from meta-analyses and Mendelian randomization studies. Mult Scler. 2020 Apr;26(4):397-404. doi: 10.1177/1352458519872664. Epub 2019 Sep 6.
PMID: 32249718BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
December 6, 2023
First Posted
June 25, 2024
Study Start
October 1, 2024
Primary Completion
October 1, 2025
Study Completion
October 1, 2025
Last Updated
June 25, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL